Hebang Bio: The price of main products has increased significantly, and the net profit in the first quarter is expected to increase by 303%-339% year-on-year.

　　Hebang BioReleased on the evening of April 11 for the first quarter of 2022performancepre-incrementannouncementthe company expects to be attributable to listed companies in the first quarter of 2022shareholderofnet profit1.01 billion yuan to 1.1 billion yuan, a year-on-year increase of 302.72%-338.6%; it is expected to achieve a net profit of 1.01 billion yuan to 1.1 billion yuan attributable to shareholders of listed companies after deducting non-recurring gains and losses, a year-on-year increase of 305.18%-341.28%.

Regarding the reasons for the changes in performance, the announcement stated that during the reporting period, the price of the company’s main product ammonium chloride (mainly used for the production of compound fertilizers) increased significantly year-on-year, hitting a new high in recent years; There was a significant increase over the same period last year. At the same time, under the guidance of the development strategy of “focus, professionalism, excellence, and strength”, the company has continuously improved the level of cost control through measures and means such as independent technological innovation, process innovation, and the introduction of advanced technology, which has provided the company with Good profit space creates technical conditions. In addition, the second phase of the company’s employee stock ownership plan will be completed in January 2022 through non-transaction transfer. It is estimated that the expenses to be recognized in the first quarter of 2022 due to this matter will be 104 million yuan, which will be included in the profit and loss of the reporting period.

(Article source: ChinasecuritiesReport · China Securities Network)

Article source: China Securities Journal China Securities Network

Responsible editor: 92

Original title: Hebang Bio: The price of main products has increased significantly, and the net profit in the first quarter is expected to increase by 303%-339% year-on-year